Please login to the form below
Debiopharm
This page shows the latest Debiopharm news and features for those working in and with pharma, biotech and healthcare.
Merck and Roche team up for hepatitis C studies
Meanwhile, a range of other new HCV drugs are coming through the pharma industry's pipelines, including Novartis and Debiopharm's DEB025, Boehringer Ingelheim's BI 201335, Bristol-Myers Squibb 's
Latest news
-
More Eloxatin settlements for sanofi-aventis
Mayne/Hospira, MN/Par and Actavis have all settled outstanding litigation regarding certain formulations of Eloxatin, currently under licence by S-A and Debiopharm.
-
Sanofi-aventis settles Eloxatin lawsuits
medicine. S-A, who hold patent rights for the drug along with Swiss-based Debiopharm, did not give any other details regarding the recent settlements, including financial.
-
Novartis gain rights to hepatitis C drug
The Swiss drugmakers will make an undisclosed upfront payment to Debiopharm Group, an independent biopharmaceuticals company based in Switzerland, with Novartis receiving exclusive worldwide development and marketing rights (excluding Japan).
-
HCV hope on the horizon
The ciclosporin analogue DEBIO 025 (Debiopharm) is a first-in-class cyclophilin inhibitor that has been generally well tolerated in clinical trials to date and may have potential as an addition
-
Pandemic preparedness
Micombi (Nippon Boehringer Ingelheim, Astellas Pharma). Hypertension. Japan. Triptorelin. Salvacyl (Debiopharm).
More from news
Approximately 0 fully matching, plus 6 partially matching documents found.
Latest Intelligence
-
Pharma deals during January 2013
Debiopharm. Chugai. Licence. Exclusive worldwide licence to FF 284 in oncology.
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
Featured jobs
- Home-based Senior Medical Writer – Med Ed
-
Salary TBC
-
Account Director, Medical Education
-
Salary TBC
- Scientific Director – Medical Communications - New York or Remot...
-
$100000 - $150000
-
Senior Medical Writer
-
Salary TBC
- Senior Account Executive – Account Manager – Healthcare Advertis...
-
£32000 - £43000 Bonus Benfits
- EU Head of Business Development and Client Service
-
Exceptional packge and bonus
-
Health Consultant - Brand Comms
-
Competitive Salary
-
Digital Account Director
-
Salary TBC
-
Creative/ Medical Writer
-
Circa £35, 000 With Benefits
- Account Manager, Medical Communications and Marketing
-
£30, 000 – £40, 000 benefits and bonus
- Science Writer, Healthcare Advertising Agency
-
£40, 000 - 45, 000 DOE benefits,
- Senior Account Manager, Medical Communications, London
-
Excellent package
- Home based, Senior Medical Writer, Medical Communications
-
Excellent package
- Freelance Senior Account Manager / Account Director - Healthcare...
-
£350-400 depending on experience
Subscribe to our email news alerts
- Brain power: fresh approaches to Alzheimer’s drug discovery
- Roche, AbbVie hit by clinical hold for Venclexta in myeloma
- BMS defends Celgene buyout ahead of shareholder vote
- Apple Watch shows promise in heart study, but doctors sceptical
- Is May’s Brexit deal sinking after Speaker's procedural torpedo?
- Roche gets FDA nod for Tecentriq in small cell lung cancer
PMHub
wethepeople
wethepeople are bringing human appeal back to brand communications. Our approach allows us to create strategies, ideas and experiences that...
Latest intelligence
- Brain power: fresh approaches to Alzheimer’s drug discovery
- New alliances are learning from past mistakes and breaking down research barriers...
- Genomics integration: can the NHS rise to the challenge?
- Experts gather to discuss the UK’s genomic landscape...
- “Brexit has been a catalyst for UK clinical research... it’s turbocharged change”
- The UK clinical trials environment has been transformed in recent years – but can it really buck Brexit’s risks and uncertainties?...
Quick links
Infographics
